MRI联合PSA策略在PSA≤20 ng/mL患者中优化活检决策:纵向观察
该纵向观察研究纳入881例疑似前列腺癌且PSA≤20 ng/mL的患者,比较PSA、MRI及PSA联合MRI对前列腺癌的诊断性能。联合策略虽敏感度低于单独PSA(0.679 vs 0.938),但特异度和阳性预测值显著提高,阴性预测值相当,可避免不必要活检。
要点
- PSA≤20 ng/mL患者中,联合MRI可提高特异性至0.833,减少不必要的活检。
- 联合策略敏感度0.679低于单独PSA 0.938,但阴性预测值相当(0.929 vs 0.924)。
- 在PSA灰区及更高PSA患者中,联合策略的PPV和NPV均优于单独PSA。
诊断标准与关键数值
- 联合策略(PSA+MRI)检测临床显著癌(CSC)的特异度0.833、阳性预测值0.567。
- 单独PSA≥4 ng/mL检测CSC的特异度0.248、阳性预测值0.0219。
- 联合策略敏感度0.679,低于单独PSA的0.938;阴性预测值0.929 vs 0.924。
临床应用与阅片要点
- 对PSA≤20 ng/mL的疑似前列腺癌患者,建议活检前进行MRI,以降低假阳性、避免不必要活检。
- 需注意联合策略敏感度较低,阴性结果不能完全排除前列腺癌,应结合临床随访。
局限性
- 纵向观察性设计可能存在选择偏倚。
- 未报告多中心数据,外推性需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To assess the diagnostic performances of prostate specific antigen (PSA) and PSA with prostate magnetic resonance imaging (MRI) to predict prostate cancer in patients with PSA ≤ 20 ng/mL.
MATERIALS AND METHODS: Patients suspected of prostate cancer with a PSA test and prebiopsy MRI were included (n = 881). Prostate biopsy results or follow-up clinical data for 2 years were used to determine the presence of prostate cancer. The diagnostic performance of PSA, MRI, and PSA with MRI (referred to as the protocol) was evaluated. The positive predictive value (PPV) and negative predictive value (NPV) of the MRI were calculated in subgroups of patients with specific ranges of PSA level.
RESULTS: Prostate cancer and CSC were diagnosed in 220 and 162 patients, respectively. Adding MRI to PSA could greatly improve specificity and PPV (0.833 and 0.567) for detecting CSC, compared to PSA ≥ 4 ng/mL alone (0.248 and 0.0219). Even though the sensitivity of the protocol (0.679) was lower than PSA (0.938), the NPV of the protocol was comparable to PSA (0.929 vs. 0.924). The protocol consistently showed the superior PPV and NVP to PSA only in not only patients within the gray zone of PSA, but also in patients with higher PSA.
CONCLUSION: In conclusion, this longitudinal observational study confirmed that adding prebiopsy MRI to PSA was consistently beneficial in patients with PSA ≤ 20 ng/mL for avoiding unnecessary biopsy despite decrease in the sensitivity.
引用
- Choi, Ha, Park, et al. Combined MRI and PSA Strategy Improves Biopsy Decisions Compared with PSA Only: Longitudinal Observations of a Cohort of Patients with a PSA Level Less Than 20 ng/mL. Acad Radiol. 2022. PMID: 36127254. doi:10.1016/j.acra.2022.07.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。